Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and upped its earnings guidance for the third straight quarter. Shares rose more than 1%, shaking off an initially …
It appears more investors are eyeing dividend stocks ahead of the Federal Reserve’s interest rate decision in September. Paul Baiocchi of SS&C ALPS Advisors thinks it is a sound strategy …
The Federal Reserve may have new incentives in the second quarter to cut rates deeper this year. Canaccord Genuity’s Tony Dwyer thinks a deteriorating jobs market and easing inflation will …
There may be a stronger case to invest in single stocks over exchange-traded funds in the weight loss space. Amplify ETFs and Roundhill Investments each filed a prospectus last week …
The top holdings of many ESG funds may be surprisingly familiar. While these strategies consider a company’s environmental, social and governance factors, these funds still aim to invest in top …
Evercore ISI’s Julian Emanuel thinks Nvidia’s monster rally is fueling a fear of missing out in the market. He finds clients, including many who traded through the dot-com boom and …
Investors may want to consider putting money to work in a lagging part of the market. According to VanEck CEO Jan van Eck, oil stocks are getting a raw deal. …
Wells Fargo Securities is officially out with its 2024 stock market forecast. Chris Harvey, the firm’s head of equity strategy, sees a volatile path to his S&P 500 to 4,625 …
Legendary value investor Jeremy Grantham is betting on a special caliber of stocks with his firm’s first active ETF: the GMO U.S. Quality ETF. And he put GMO partner Tom …